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ABSTRACT
Background: Dietary protein may slow the decline in muscle mass
and function with aging, making it a sensible candidate to prevent
or modulate disability progression. At present, studies providing
reliable estimates of the association between protein intake and
physical function, and its interaction with physical activity (PA), in
community-dwelling older adults are lacking.
Objectives: We investigated the longitudinal relation between
protein intake and physical function, and the interaction with PA.
Methods: We undertook a pooled analysis of individual participant
data from cohorts in the PROMISS (PRevention Of Malnutrition
In Senior Subjects in the European Union) consortium (the Health
Aging and Body Composition Study, Quebec Longitudinal Study
on Nutrition and Successful Aging, Longitudinal Aging Study
Amsterdam, and Newcastle 85+) in which 5725 community-
dwelling older adults were followed up to 8.5 y. The relation between
protein intake and walking speed was determined using joint models
(linear mixed-effects and Cox proportional hazards models) and the
relation with mobility limitation was investigated using multistate
models.
Results: Higher protein intake was modestly protective of decline in
walking speed in a dose-dependent manner [e.g., protein intake ≥1.2
compared with 0.8 g/kg adjusted body weight (aBW)/d: β = 0.024,
95% CI: 0.009, 0.032 SD/y], with no clear indication of interaction
with PA. Participants with protein intake ≥0.8 g/kg aBW/d had
also a lower likelihood of incident mobility limitation, which was
observed for each level of PA. This association seemed to be dose-
dependent for difficulty walking but not for difficulty climbing stairs.
No associations between protein intake and other mobility limitations
transitions were observed.
Conclusions: Higher daily protein intake can reduce physical
function decline not only in older adults with protein intake below the
current RDA of 0.8 g/kg BW/d, but also in those with a protein intake
that is already considered sufficient. This dose-dependent association
was observed for each level of PA, suggesting no clear synergistic
association between protein intake and PA in relation to physical
function. Am J Clin Nutr 2021;00:1–13.
Keywords: protein, walking speed, gait speed, physical activity,
joint models, PROMISS, older adults, one-stage meta-analysis
Introduction
Life expectancy has reached 81.0, 82.1, and 78.7 y in the
European Union, Canada, and United States, respectively (1–3).
However, the increase in healthy life years (HLYs)—the number
of years an individual can expect to live disability-free—has
not kept pace (4). Bridging the gap between life expectancy
and HLYs by compressing morbidity into the later years of life
is of special interest, not only to increase quality of life, but
also to relieve the immense strain on the health care systems of
developed countries.
Diet is a major modifiable risk factor for the development and
management of a range of age-related diseases that comprise
the leading causes of morbidity, disability, and death (5, 6).
Specifically, dietary protein can slow the decline of muscle
mass and function with aging, making it a sensible candidate to
prevent or modulate disability progression (7–9). For example,
community-dwelling older adults (70–79 y) with lower protein
intake [<1 g/kg body weight (BW)/d] from the Health Aging and
Body Composition Study (Health ABC) study had an increased
risk of mobility limitation over 6 y compared with those with
higher protein intake (≥1 g/kg BW/d) (10). In the Newcastle
85+ Study, community-dwelling very old adults (≥85 y) with
protein intake <1 compared with ≥1 g/kg adjusted body weight
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(aBW)/d had lower muscle strength over 5 y (9). However, at
present, evidence for an association between protein intake and
(performance-based) loss of physical function in older adults is
limited. One study in older females showed that higher protein
intake was associated with a slower rate of physical function
decline (11), but other studies did not find protein intake to be
associated with less decline in physical function (9, 12–15).
Inadequate protein intake is a cause for concern in older
adults because protein intake is lower in older males (87
g/d) and females (69 g/d) than in their younger counterparts
(97 g/d and 73 g/d, respectively) (16, 17) due to multimorbidity,
tooth loss, changes in deglutition, appetite loss, and loss of
functional independence (18). Additionally, a higher prevalence
of disease-related tissue catabolism and inflammation, and
anabolic resistance can offset protein requirements (19, 20).
Expert groups, such as PROT-AGE, have suggested a possible
synergistic protective effect of protein and physical activity (PA)
on age-related loss of muscle strength and muscle function (18).
This would be anticipated if higher PA and higher protein intake
together were necessary to optimally stimulate the rate of muscle
synthesis, which might consequently decrease the rate of loss of
muscle mass and muscle function and slow the rate of functional
decline in older adults. However, only a few cohort studies
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have addressed this issue (9, 12) and evidence from randomized
controlled trials (RCTs) is inconclusive (21–23). This could be
due to a lack of statistical power in individual studies, which
can be overcome by pooling individual participant data from
multiple studies. We hypothesized that higher protein intake
(especially ≥1 g/kg aBW/d), alone or in combination with PA,
is protective against physical function loss. We therefore aimed
to: 1) investigate the prospective relation between protein intake
and physical function (using objective and subjective measures);
and 2) explore the interaction between protein intake and PA in
relation to physical function in 4 longitudinal aging cohorts in the




As part of the PROMISS consortium, 4 longitudinal prospec-
tive observational studies were included: 1) the Health, Aging
and Body Composition Study (Health ABC); 2) the Quebec
Longitudinal Study on Nutrition and Successful Aging (NuAge);
3) the Longitudinal Aging Study Amsterdam (LASA); and 4) the
Newcastle 85+ Study (Figure 1). These studies are described in
detail elsewhere (24–27). Briefly, Health ABC is a longitudinal
cohort study that included 3075 well-functioning community-
dwelling black and white males and females aged 70–79 y living
in the United States at baseline. Participants were recruited from
Medicare-eligible residents in the metropolitan areas of Mem-
phis, Tennessee, and Pittsburgh, Pennsylvania, between April
1997 and June 1998 and followed annually (clinic visit) or every
6 mo (telephone interview) for 16 y (24). We used year 2 (base-
line) and follow-up data until year 10. NuAge is a longitudinal
cohort that recruited 1793 generally healthy community-dwelling
males and females aged 67–84 y living in Montreal and Sher-
brooke areas (Quebec, Canada) in 2003–2005 and followed them
annually (clinic visit) or every 6 mo (telephone interview) for 3
y (27). We used data from baseline and all 3 follow-up waves for
all participants who agreed to be part of the NuAge Database and
Biobank (n = 1754 at baseline). LASA is an ongoing nationally
representative longitudinal study of older males and females
aged ≥55 y residing in The Netherlands. The study started in
1992/93 (n = 3107) and participants were followed every 3
y until 2018/2019 (most recent wave: wave J). Two additional
cohorts were recruited from the same sampling frames at 10 y
(2002/2003, n = 1002) and 20 y (2012/2013, n = 1023) after
the baseline (25). We used data from wave 3B (2012/2013), the
Nutrition and Food-related Behaviour substudy (2014/2015) and
wave I (2015/2016). The Newcastle 85+ Study is a longitudinal
population-based study that approached all people turning 85 y
in 2006/2007 (born in 1921) in Newcastle and North Tyneside,
United Kingdom. At baseline, there were 845 very old males and
females who agreed to a health assessment and a review of their
GP records (26), and who were re-examined after 18, 36, and 60
mo. We used data from baseline and all 3 follow-up waves.
Exclusion criteria
We excluded participants (Figure 1) who were institutionalized
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FIGURE 1 Flowchart of the 4 longitudinal aging cohorts included and the exclusion criteria for the analytic sample. Very low cognitive status was defined
by a Mini-Mental State Examination score <18 or having dementia. Very high energy intakes were defined as >3500 kcal/d for females or >4000 kcal/d
for males. The final sample depends on the availability of walking speed, self-reported ability to walk >200 m, or ability to climb stairs (hence a range of n
is given). Health ABC, Health, Aging and Body Composition Study; LASA, Longitudinal Aging Study Amsterdam; N85+, Newcastle 85+ Study; NuAge,
Quebec Longitudinal Study on Nutrition and Successful Aging.
Mini-Mental State Examination or with diagnosed dementia) and
no proxy for dietary assessment (n = 18), had missing dietary
intake data (n = 800), had very high reported energy intake,
that is, >3500 kcal/d for females or >4000 kcal/d for males
(n = 52), or had no data on BMI (n = 58). The analytic sample
comprised 5658–5725 (depending on the outcome, i.e., walking
speed, difficulty walking >200 m, or difficulty climbing stairs)
community-dwelling participants aged ≥55 y.
Missing and nonmissing data on walking speed and mobility
limitation
Older adults who were smokers, had lower energy intake, low
PA, and had more mobility limitation had more missing data
on walking speed. Those with low education, poor cognitive
status, non–alcohol drinkers, low PA, and slower walking speed
had more missing data on mobility limitation (Supplemental
Table 1).
Dietary assessment
Dietary intake was assessed by an FFQ in Health ABC and
LASA, and by multiple 24-h recalls in NuAge and Newcastle
85+. In Health ABC, a 108-item interviewer-administered FFQ
(28) that reflected the preceding 12 mo was used at the first
follow-up (year 2; 1998/1999) and served as the baseline for the
present study. In LASA, a validated (29) self-administered 238-






/ajcn/advance-article/doi/10.1093/ajcn/nqab051/6214582 by guest on 20 April 2021
4 Mendonça et al.
LASA, dietary intake was not assessed at a regular measurement
cycle, but in the Nutrition and Food-related Behavior Study
2014–2015 substudy. In NuAge, 3 recalls per wave were collected
by trained registered dietitians on 2 randomly chosen weekdays
and 1 weekend day, 1 face-to face and 2 by telephone (27).
Portion sizes were estimated with the aid of portion size models.
In the Newcastle 85+ Study, two 24-h recalls were collected
by trained research nurses on 2 nonconsecutive weekdays
≥1 wk apart (31, 32) and portion sizes were estimated with
the aid of a photographic food atlas. In all studies, energy and
protein intake were calculated by using country-specific food
composition databases. In studies that assessed dietary intake
using 24-h recall, individual intakes of protein and energy were
averaged within the 2 (Newcastle 85+) or 1 or 3 (NuAge)
measurements. Dietary intake was available at baseline for Health
ABC, LASA, and Newcastle 85+, and at baseline and waves 2,
3, and 4 for NuAge.
For participants with an undesirable body weight (BW), BW
was adjusted to be within the desired BMI for older adults of
22–27 kg/m2 and calculated as previously described (33, 34).
By this, we attempted to control for the deficit and excess in
BW in underweight and overweight people, respectively. All
variables are described in Supplemental Table 2. Protein intake
was expressed as a categorical variable using cut points of
<0.8, 0.8–0.99, 1.0–1.19, and ≥1.2 g/kg BW/d and g/kg aBW/d.
These cutoffs were based on expert recommendations for optimal
protein intake (18, 20), on currently used RDAs for protein [e.g.,
0.8 is recommended by the European Food Safety Authority
(EFSA) (35) and the Institute of Medicine (IoM) (36), 1.0 by the
European DACH (Germany, Austria, and Switzerland) countries
(37), and 1.2 by the European Nordic countries (38)], and on
previously published studies on protein intake in older adults (9,
24, 34, 39–43).
Physical activity
In Health ABC, total PA was measured (at baseline) by a
specifically designed self-reported questionnaire as described
previously (44). Participants indicated whether they had per-
formed exercise (part of daily routine or leisure-time) in the
past 7 d and how long they spent in each activity. These
included gardening, heavy chores, light housework, grocery
shopping, laundry, climbing stairs, walking, and moderate- and
high-intensity exercise. A metabolic equivalent (MET) value in
kilocalories per week per kilogram BW was determined for
each activity. A total PA score was calculated as the sum of
the MET values for each activity multiplied by the participant’s
BW in kilograms. In NuAge, PA was measured using the self-
reported Physical Activity Scale for the Elderly (45). This
validated questionnaire included work-related, household, and
leisure time activities during a 1-wk period. The total PA score
is derived from multiplying the amount of time spent on each
activity (in hours per week) by the item weights and summing
over all activities (46). PA in LASA was measured with a
validated interviewer-administered questionnaire that estimates
the frequency, duration, and intensity of specific activities in
the previous 2 wk (47). These included walking, cycling, light
and heavy household work, and first and second sport. MET
scores were assigned to each activity based on published lists
of MET scores (48). For each activity, the frequency, duration
in minutes, and MET score were multiplied and then divided
by 14 d. The minutes spent per activity per day were summed
to a total PA score (minutes/day × MET). In Newcastle 85+,
a validated purposely designed physical activity questionnaire
included questions on how frequently [≥3 times/wk (score of
3), 1–2 times/wk (score of 2), 1–3 times/mo (score of 1), and
hardly ever (score of 0)] the participants engaged in mildly
energetic (e.g., light gardening, light housework), moderately
energetic (e.g., moderate gardening, walking at moderate pace,
heavy housework), and highly energetic (e.g., heavy gardening,
swimming, cycling) activities. The resulting total PA score was
calculated as 3 × highly energetic activities + 2 × moderately
energetic activities + mildly energetic activities (49). PA was
transformed into cohort-specific tertiles (categorized as low,
medium, and high) at baseline, which were used to categorize
the PA score for subsequent waves.
Walking speed
Walking speed was used as an objective (performance-based)
measure of physical function. Walking speed (meters per second)
was measured as the time (seconds) taken to walk a preset
distance—20 m in Health ABC, 4 m in NuAge, and 3 m
in LASA—at usual speed and calculated as distance (meters)
divided by time (seconds). In Newcastle 85+, Timed-Up-
and-Go (TUG) was measured instead of walking speed. To
harmonize Newcastle 85+ with the other cohorts, the formula
[6/TUG (s)]×1.62 was used to yield walking speed (m/s), as
recommended (50).
Mobility limitation
Self-reported difficulty walking >200 m and climbing stairs
were used as subjective measures of physical function and are
here defined under the broad heading of mobility limitations. In
Health ABC, difficulty walking was determined by asking the
participants if they had any difficulty walking a quarter mile
(400 m) because of a health or physical problem; difficulty in
climbing stairs was determined by asking the participants if they
were able to climb 1 flight of stairs (∼10 steps). In NuAge,
participants were asked if their health status prevented them from
walking >200 m and if they could go up and down a staircase
(∼10 steps). In LASA, participants were asked if they had any
difficulty walking for 5 min outside the house without stopping
(equivalent to 240 m if walking speed was 0.8 m/s), and if they
could walk up and down a staircase of 15 steps without resting. In
Newcastle 85+, participants were asked if they had any difficulty
walking ≥400 yards (366 m) and if they could go up and down
stairs. Difficulty walking was harmonized by creating a binary
variable: able to walk >200 m without difficulty, or not (with
some difficulty, with help, or unable). Difficulty climbing stairs
was harmonized as being able to climb stairs without difficulty or
not (with some difficulty, with help, or unable).
Mortality
In Health ABC, deaths were confirmed by death certificate and
review of hospital records, obituaries, and interviews with family
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age at baseline (1998/1999) and age of death or September 30,
2014, whichever came first. In NuAge, deaths were recorded
during data collection. Age at baseline (2003–2005) and deaths
(censored at May 3, 2010) were used to calculate the time
to death. LASA was linked with mortality data of Statistics
Netherlands (Centraal Bureau voor de Statistiek). Time to death
was calculated as the time from baseline age (2012/2013) to
death or July 22, 2018, whichever came first. In Newcastle 85+,
information on date of death was provided by National Health
Service Digital UK, and time to death was calculated as the time
between baseline age (2006–2007) and age at death (censored at
January 16, 2018).
The methods used to assess education, BMI, smoking, alcohol
drinking, multimorbidity, and cognitive status in each cohort are
described in the Supplemental Methods. All variables used and
their operationalization are described in Supplemental Table 2.
Ethics approval and consent to participate
Health ABC was approved by the institutional review boards
of the University of Tennessee, Memphis, Tennessee, and
the University of Pittsburgh, Pittsburgh, Pennsylvania. LASA
was approved by the medical ethics committee of the VU
University Medical Center. The Newcastle 85+ Study was
approved by the Newcastle & North Tyneside Local Research
Ethics Committee 1. Signed consent was obtained from each
participant, and a signed consultee approval was obtained
whenever the patient lacked capacity. NuAge was approved
by the ethics committees of both the University Institutes of
Geriatrics of Sherbrooke and Montréal and the Research Ethics
Board of the McGill University Health Centre. All studies were
conducted in line with the Declaration of Helsinki, and all
participants provided written informed consent and/or a signed
consultee approval was obtained whenever the participant lacked
capacity.
Statistical analyses
Data cleaning, quality control, and harmonizing were per-
formed separately for each cohort prior to merging. Because the
methods to assess energy intake and walking speed were different
between cohorts, these were transformed into cohort-specific z-
scores [z = (x −μ)/σ )]. For walking speed, the baseline mean and
SD was used to create z-scores for the other waves. Normality
was assessed by Q-Q plots: normally distributed variables are
presented as means and SDs, non-Gaussian distributed variables
as medians and IQRs, and categorical data as percentages (with
corresponding frequency). To determine the relation between
protein intake and walking speed we performed hierarchical
linear mixed effects models with the lme4 package (version
1.1-20) (51) and Cox proportional hazards for time-to-event
data (mortality) with the survival package (version 2.43-3) (52).
Data missing at random were accounted for in the linear mixed
models. However, as in any longitudinal cohort of aging, attrition
was high (53) and failure to account for mortality (nonrandom
attrition) would likely result in biased estimates toward the
null (54). These outcomes (walking speed and mortality) are
typically analyzed separately, but joint models analyze the 2
outcomes together with shared parameters in a single likelihood
function (maximum likelihood estimation). We therefore fitted
joint models with the JoineRmeta package (version 0.1.2) (55) in
R v3.6.3. To determine the association between protein intake and
transitions in mobility limitation (i.e., difficulty walking >200
m and difficulty climbing stairs) we fitted multistate models
with 3 states: no limitation, limitation, and death (absorbing
state); the illness-death model with the allowed transitions is
shown in Supplemental Figure 1. Multistate models describe the
movement of an individual between a number of finite states in a
continuous time stochastic process under the Markov assumption
that the next state is only influenced by the current state (56, 57).
Multistate models were fitted with the msm package in R v3.2.2
(58). For walking speed and mobility limitation (i.e., difficulty
walking and difficulty climbing stairs), we fitted 3 models with
increasing complexity with protein intake <0.8, 0.8–0.99, 1.0–
1.19, and ≥1.2 g/kg BW/d (actual BW) and g/kg aBW/d (adjusted
BW) as the primary exposure. Separate models for walking speed
and mobility limitation were also stratified by PA level. Model l
included protein intake, study (random effect in the joint models),
age, sex, and education; Model 2 was adjusted for the previous
variables plus energy intake, smoking, and alcohol drinking;
Model 3 was further adjusted for multimorbidity, cognitive status,
and PA (except if the model was stratified by PA level). Point
estimates and CIs were used to assess statistical and clinical
significance. Results are presented as βs and 95% CIs for
the joint models, and as HRs and 95% CIs for the multistate
models.
Results
Health and sociodemographic characteristics and functional
status
The analytic sample consisted of 5725 participants with a
median age of 75.0 y (IQR: 71.6–79.0 y) at baseline, 53% of
which (n = 3035) were females (Table 1). Most participants
were from the Health ABC study (46.5%), followed by NuAge
(30.1%), Newcastle 85+ (12.6%), and LASA (10.8%) at baseline
(Table 1, Figure 1). At baseline, 28%, 23%, 21%, and 28% of
the participants had protein intake <0.8, 0.8–0.99, 1.0–1.19, and
≥1.2 g/kg aBW/d, respectively (Table 1). The protein intake
groups were of similar age (age was “statistically” different
but this difference was not meaningful), sex ratio, education,
multimorbidity, cognition, and smoking status, but differed in
alcohol consumption and energy intake (higher protein intake
category included a higher proportion of alcohol drinkers and
higher energy intake) and in PA (e.g., 29.6% of those with
protein intake ≥1.2 g/kg aBW/d had a low level of PA,
whereas this was 36.7% in those with protein intake <0.8 g/kg
aBW/d). Participants with higher protein intake had slightly
faster walking speed (z-score) and were less likely to have
mobility limitation (Table 1). Maximum follow-up time was
8.5 y (mean: 2.5 ± 2.4 y). Walking speed decreased modestly
with age (from 1.06 ± 0.28 m/s at baseline to 1.01 ± 0.25 m/s
at wave 4, and 1.03 ± 0.23 m/s at wave 5), and the proportion
of participants with mobility limitation increased with age [e.g.,
18% (n = 1031) of participants had difficulty walking >200 m at
baseline, and this increased to 30.2% (n = 1092) at wave 4 and
35.4% (n = 605) at wave 5] (Supplemental Figure 2, Table 2).
Health and sociodemographic characteristics by protein intake







/ajcn/advance-article/doi/10.1093/ajcn/nqab051/6214582 by guest on 20 April 2021











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































/ajcn/advance-article/doi/10.1093/ajcn/nqab051/6214582 by guest on 20 April 2021
Protein intake and physical function in older adults 7











Age, y, median (IQR) 75.0 (71.6–79.0) 76.0 (73.0–80.0) 78.4 (76.0–82.0) 80.0 (77.2–83.3) 82.0 (80.0–84.0)
Females, % (n) 53.0 (3035) 53.5 (2856) 54.3 (2398) 54.6 (2172) 54.9 (1023)
Cohort, % (n)
Health ABC 46.5 (2660) 46.6 (2487) 53.2 (2353) 52.4 (2085) 100.0 (1865)
NuAge 30.1 (1726) 31.2 (1666) 36.4 (1610) 39.4 (1567) 0.0 (0)
LASA 10.8 (620) 11.3 (602) 0.0 (0) 0.0 (0) 0.0 (0)
N85+ 12.6 (719) 10.9 (582) 10.3 (456) 8.2 (328) 0.0 (0)
Education, % (n)
Low 31.9 (1822) 31.0 (1651) 30.9 (1366) 30.4 (1208) 20.5 (382)
Medium 37.7 (2156) 38.0 (2025) 35.1 (1551) 35.2 (1400) 32.4 (603)
High 30.4 (1741) 31.0 (1655) 33.9 (1499) 34.4 (1368) 47.1 (878)
Multimorbidity, % (n) 51.0 (2784) 55.7 (2856) 56.1 (2396) 57.7 (2147) 58.9 (1099)
Cognition, % (n)
Low 29.9 (1660) 31.4 (1475) 30.8 (1212) 36.6 (1201) 37.1 (538)
Medium 41.7 (2319) 38.7 (1817) 38.0 (1498) 39.5 (1298) 31.9 (462)
High 28.4 (1579) 29.8 (1399) 31.2 (1230) 23.9 (786) 31.0 (449)
Smokers, % (n) 8.5 (488) 7.7 (396) 6.6 (282) 6.0 (224) 7.0 (130)
Alcohol drinkers, % (n) 44.5 (2545) 45.3 (2359) 40.6 (1738) 41.7 (1574) 37.8 (705)
Energy intake, z-score (mean ± SD) − 0.0 ± 1.0 − 0.0 ± 1.0 − 0.0 ± 1.0 − 0.0 ± 1.0 − 0.0 ± 1.0
Protein intake, g/kg BW/d, % (n)
<0.8 33.6 (1924) 34.0 (1752) 36.8 (1566) 36.7 (1373) 45.5 (848)
0.8–0.99 23.3 (1332) 23.2 (1198) 22.9 (976) 22.4 (838) 21.2 (395)
1.0–1.19 19.3 (1107) 19.0 (981) 18.2 (773) 18.5 (691) 15.7 (292)
≥1.2 23.8 (1362) 23.8 (1227) 22.1 (942) 22.5 (842) 17.7 (330)
Protein intake, g/kg aBW/d, % (n)
<0.8 27.6 (1579) 28.1 (1427) 30.4 (1293) 30.0 (1117) 39.4 (734)
0.8–0.99 23.3 (1335) 23.1 (1173) 24.5 (1043) 23.7 (881) 22.6 (421)
1.0–1.19 21.3 (1218) 20.8 (1056) 19.7 (836) 20.9 (777) 17.4 (324)
≥1.2 27.8 (1593) 27.9 (1415) 25.4 (1078) 25.5 (948) 20.7 (386)
Physical activity, % (n)
Low 32.3 (1849) 37.9 (1933) 44.8 (1848) 43.7 (1541) 51.0 (870)
Medium 33.8 (1935) 39.7 (2025) 31.2 (1287) 32.0 (1127) 30.1 (514)
High 33.9 (1937) 22.5 (1146) 24.1 (993) 24.3 (856) 18.9 (322)
Walking speed, m/s (mean ± SD) 1.06 ± 0.28 1.06 ± 0.29 1.03 ± 0.27 1.01 ± 0.25 1.03 ± 0.23
Walking speed, z-score (mean ± SD) − 0.00 ± 1.00 − 0.02 ± 1.00 − 0.14 ± 1.05 − 0.28 ± 1.06 − 0.53 ± 1.08
Mobility limitation, % (n)
Difficulty walking >200 m 18.0 (1031) 21.2 (1048) 25.2 (981) 30.2 (1092) 35.4 (605)
Difficulty climbing stairs 21.3 (1208) 24.2 (1233) 30.0 (1246) 31.5 (1129) 25.5 (414)
1Not all waves are at the same time of follow-up among cohorts. In Health ABC the necessary variables were available at year 2 (operationalized as
baseline), 4 (wave 2), 6 (wave 3), 8 (wave 4), and 10 (wave 5). In NuAge data were available at year 1 (baseline), 2 (wave 2), 3 (wave 3), and 4 (wave 4). In
LASA variables were available at wave 3B (baseline) and at wave I after 3 y (wave 2). The Newcastle 85+ has data at baseline, after 18 mo (wave 2), after
36 mo (wave 3), and after 60 mo (wave 4). Cognition was assessed with the Mini-Mental State Examination. Smokers and alcohol drinkers represent current
consumers. z-scores and tertiles are cohort-specific. aBW, adjusted body weight; BW, body weight; Health ABC, Health, Aging and Body Composition
Study; LASA, Longitudinal Aging Study Amsterdam; N85+, Newcastle 85+ Study; NuAge, Quebec Longitudinal Study on Nutrition and Successful
Aging.
Protein intake and walking speed
In the model adjusted for sex, age, and education, walking
speed (z-score) decreased on average by 0.107 SD (95% CI:
−0.116, −0.100) per year. In the same model, higher protein
intake was modestly associated with faster walking speed and less
decline in walking speed over time (Figure 2A). For example,
a protein intake ≥1.2 g/kg aBW/d was associated with 0.076
SD (95% CI: 0.020, 0.117) faster walking speed and 0.024 SD
(95% CI: 0.007, 0.034) per year slower decline in walking speed
compared with a protein intake <0.8 g/kg aBW/d. There was also
evidence of a dose-dependent association between protein intake
category and decline in walking speed. The same trends remained
with further adjustment for confounding factors (e.g., energy
intake and multimorbidity) (Figure 2B, C). For example, in the
fully adjusted model, a protein intake ≥1.2 compared with
<0.8 g/kg aBW/d was associated with 0.053 SD
(95% CI: −0.011, 0.098) faster walking speed and
0.024 SD (95% CI: 0.009, 0.032) per year slower
decline in walking speed (Figure 2C). Results were
similar for protein g/kg actual BW/d (Supplemental
Table 5).
Protein intake and mobility limitation
There were 1478 incident cases (i.e., transition from no
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FIGURE 2 Association between protein intake categories (g/kg aBW/d) and walking speed (z-score) over time (β coefficients and 95% CIs). The analytic
sample consisted of 5725 participants. A joint model (hierarchical linear mixed effects and Cox proportional hazards models) was fitted to assess the association
between protein intake and walking speed over time. Model 1 (A) is adjusted for categories of adjusted protein intake, sex, age, and education. Model 2 (B) is
further adjusted for energy, smoking, and alcohol intake, and Model 3 (C) is further adjusted for cognition, multimorbidity, and physical activity. aBW, adjusted
body weight.
m and 742 who recovered (Table 3). There were also 1612
incident cases of difficulty climbing stairs and 932 who recovered
(Table 4) from one wave to another (mean: 1.70 ± 0.55 y between
each wave). In the fully adjusted models, higher protein intake
was associated with a lower incidence of mobility limitation
(for both difficulty walking >200 m and difficulty climbing
stairs). Participants with a protein intake of 0.8–0.99 g/kg aBW/d
were 16% less likely to develop difficulty walking (HR: 0.84;
95% CI: 0.72, 0.99) (Table 3) and 22% less likely to develop
difficulty climbing stairs (HR: 0.78; 95% CI: 0.67, 0.92) (Table 4)
compared with participants with protein intake <0.8 g/kg aBW/d.
This protective association was also observed for a protein intake
of 1.0–1.19 g/kg aBW/d (difficulty walking, HR: 0.71; 95%
CI: 0.59, 0.86; difficulty climbing stairs, HR: 0.76; 95% CI:
0.63, 0.91), and of ≥1.2 g/kg aBW/d (difficulty walking, HR:
0.69; 95% CI: 0.56, 0.84; difficulty climbing stairs, HR: 0.76;
95% CI: 0.62, 0.92) compared with <0.8 g/kg aBW/d. Higher
protein intake, even in participants with a protein intake ≥0.8
g/kg aBW/d, seemed to be beneficial for lower incidence of
difficulty walking (Table 3), but not for difficulty climbing stairs,
where all protein intake categories >0.8 cutoff had similar HRs
(Table 4). No associations between protein intake and other
transitions of mobility limitation were observed. Results were
similar for protein in g/kg actual BW/d (Supplemental Tables 6
and 7).
Interaction of protein intake with PA
The fully adjusted model for protein intake and walking speed
was stratified by low, medium, and high PA (Supplemental
Figure 3). Although there was a trend within the same PA
category for a slightly slower decline in walking speed for
higher protein intake [e.g., participants with ≥1.2 compared with
<0.8 g protein/kg aBW/d and medium PA had a slower decline
in walking speed of 0.03 SD (95% CI: 0, 0.05)/y], there was
no evidence of other associations (Supplemental Figure 3).
No interactions between protein intake and PA were observed
for any of the transitions between mobility limitation (i.e.,
difficulty walking and climbing stairs), except for incident
mobility limitation. For the latter, we ran the same fully
adjusted models by PA category (Figure 3) and observed
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TABLE 3 HRs and 95% CIs for the contribution of protein intake categories to transitions in self-reported difficulty walking1
Protein intake, g/kg aBW/d
<0.8 (ref.) 0.8–0.99 1.0–1.19 ≥1.2
HR HR 95% CI HR 95% CI HR 95% CI
Incident mobility limitation (n = 1478)
Model 1 1.0 0.90 0.79, 1.04 0.82 0.71, 0.96 0.83 0.72, 0.95
Model 2 1.0 0.83 0.72, 0.97 0.72 0.60, 0.85 0.68 0.56, 0.82
Model 3 1.0 0.84 0.72, 0.99 0.71 0.59, 0.86 0.69 0.56, 0.84
No mobility limitation to death (n = 542)
Model 1 1.0 1.07 0.71, 1.59 1.24 0.84, 1.84 1.20 0.82, 1.76
Model 2 1.0 1.02 0.68, 1.52 1.13 0.74, 1.73 1.00 0.61, 1.64
Model 3 1.0 1.04 0.69, 1.56 1.20 0.78, 1.85 1.08 0.66, 1.78
Recovery from mobility limitation (n = 742)
Model 1 1.0 0.98 0.79, 1.20 0.98 0.79, 1.23 1.05 0.85, 1.29
Model 2 1.0 1.03 0.82, 1.30 1.04 0.81, 1.34 1.10 0.82, 1.48
Model 3 1.0 1.03 0.81, 1.32 1.06 0.81, 1.39 1.09 0.80, 1.48
Mobility limitation to death (n = 557)
Model 1 1.0 0.98 0.82, 1.16 0.98 0.81, 1.19 0.98 0.81, 1.17
Model 2 1.0 1.06 0.88, 1.27 1.10 0.89, 1.36 1.16 0.92, 1.46
Model 3 1.0 1.10 0.91, 1.33 1.13 0.91, 1.41 1.20 0.95, 1.52
1Multistate models were used to determine the association between protein intake and transitions in difficulty walking. Model 1 is adjusted for categories
of adjusted protein intake, sex, age, and education. Model 2 is further adjusted for energy intake, smoking, and alcohol intake, and Model 3 is further adjusted
for cognition, multimorbidity, and physical activity. aBW, adjusted body weight; ref., referent.
likelihood of transitioning from no mobility limitation to mobility
limitation for both difficulty walking and difficulty climbing
stairs, and within low PA and high PA but not within medium
PA. These associations seemed to be largely dose-dependent,
where participants with higher protein intake had a lower
likelihood of incident mobility limitation, even within the same
PA category. For example, participants with a protein intake
≥1.2 g/kg aBW/d and high PA were 43% less likely (HR:
0.57; 95% CI: 0.37, 0.87) than those with a protein intake <0.8
g/kg aBW/d and high PA to transition to difficulty climbing
stairs, whereas participants with a protein intake of 1.0–1.19
g/kg aBW/d were 38% less likely (HR: 0.62; 95% CI: 0.42,
0.93) and those with a protein intake of 0.8–0.99 g/kg aBW/d
were 28% less likely (HR: 0.72; 95% CI: 0.51, 1.02) to
transition to difficulty climbing stairs within the high PA category
(Figure 3).
TABLE 4 HRs and 95% CIs for the contribution of protein intake categories to transitions in self-reported difficulty climbing stairs1
Protein intake, g/kg aBW/d
<0.8 (ref.) 0.8–0.99 1.0–1.19 ≥1.2
HR HR 95% CI HR 95% CI HR 95% CI
Incident mobility limitation (n = 1612)
Model 1 1.0 0.83 0.72, 0.96 0.83 0.72, 0.97 0.82 0.71, 0.95
Model 2 1.0 0.79 0.68, 0.92 0.74 0.62, 0.88 0.70 0.58, 0.85
Model 3 1.0 0.78 0.67, 0.92 0.76 0.63, 0.91 0.76 0.62, 0.92
No mobility limitation to death (n = 608)
Model 1 1.0 1.18 0.84, 1.66 1.27 0.89, 1.81 1.13 0.80, 1.61
Model 2 1.0 1.16 0.81, 1.66 1.28 0.86, 1.91 1.07 0.67, 1.71
Model 3 1.0 1.16 0.83, 1.61 1.23 0.85, 1.79 1.12 0.73, 1.72
Recovery from mobility limitation (n = 932)
Model 1 1.0 0.88 0.73, 1.07 0.84 0.68, 1.03 0.91 0.75, 1.10
Model 2 1.0 0.89 0.73, 1.09 0.86 0.68, 1.08 0.93 0.71, 1.20
Model 3 1.0 0.91 0.73, 1.13 0.92 0.72, 1.18 1.05 0.80, 1.38
Mobility limitation to death (n = 598)
Model 1 1.0 0.89 0.75, 1.06 0.96 0.79, 1.17 0.92 0.77, 1.10
Model 2 1.0 0.98 0.81, 1.18 1.03 0.83, 1.28 1.07 0.85, 1.34
Model 3 1.0 1.01 0.83, 1.23 1.06 0.84, 1.33 1.12 0.88, 1.43
1Multistate models were used to determine the association between protein intake and transitions in difficulty climbing stairs. Model 1 is adjusted for
categories of adjusted protein intake, sex, age, and education. Model 2 is further adjusted for energy intake, smoking, and alcohol intake, and Model 3 is
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Incident limitation walking Incident limitation climbing stairs





Protein intake ≥1.2 g/kg aBW/d 1.0-1.19 g/kg aBW/d 0.8-0.99 g/kg aBW/d <0.8 g/kg aBW/d (ref.)
FIGURE 3 HRs and 95% CIs for the contribution of protein intake in grams per kilogram adjusted body weight per day to incident mobility limitations
(i.e., difficulty walking >200 m and climbing stairs) by physical activity category over time. The analytic sample for the incident limitation climbing stairs
model consisted of 1612 transitions, and for the incident limitation walking model consisted of 1478 transitions. Multistate models were used to determine
the association between protein intake and transitions to mobility limitation stratified by physical activity. The models are adjusted for categories of adjusted
protein intake, sex, age, and education, energy intake, smoking, alcohol intake, cognition, and multimorbidity and stratified by PA category at baseline. aBW,
adjusted body weight; PA, physical activity.
Discussion
To the best of our knowledge, we are the first to perform
a pooled analysis of individual participant data from multiple
longitudinal aging cohorts on the prospective association between
protein intake and (objective and subjective) physical function,
and its interaction with PA. Our study indicated that community-
dwelling older adults with protein intake higher than the EFSA’s
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objective and perceived physical function over time. Those with
protein intake ≥0.8 g/kg aBW/d had (moderate) slower decline
in walking speed and were less likely to develop self-reported
mobility limitation, with some evidence for dose-dependency.
Our study also indicated that a protein intake ≥1.0 g/kg aBW/d
was associated with less functional decline compared with an
intake of 0.8–0.99 g/kg aBW/d. We observed no synergistic
relation between protein intake and PA for maintaining physical
function over time.
Our finding that higher protein intake can be associated
with a modest decline in walking speed over a follow-up of
maximum 8.5 y is in contrast to the individual studies pooled
(9, 13, 15), and to other aging cohorts (12, 14), except one
(11). This could be explained by the larger sample size in our
study, providing more power to detect this modest association,
especially because the decline in walking speed was small
(prior to z-score transformation it declined by 0.05 m/s over
the study period), which could be insufficient to see a more
clinically relevant association with higher protein intake. Our
study mostly comprised well-functioning older adults at baseline,
among whom the rate of functional decline might be slower
than those who are frailer and/or have more comorbidities (59).
Two recent meta-analyses of RCTs of protein supplementation
and physical performance, in nonfrail and frail/ill older adults
(22, 60), support this. That in nonfrail older adults failed to
show an effect of protein supplementation on walking speed (22),
whereas that in frail and ill older adults showed that protein
supplementation improved physical function (60).
Regarding protein intake and mobility limitations, our finding
that older adults who consumed ≥0.8 g protein/kg aBW/d were
less likely to develop mobility limitations, compared with those
with a protein intake <0.8 g/kg aBW/d, was in line with previous
studies in individual cohorts used in this study (10, 61) and in
other aging cohorts (12, 62–64). We observed no associations
between protein intake and other mobility limitation transitions,
that is, from no mobility limitation to death, recovery from
mobility limitation, or from mobility limitation to death. These
findings suggest that higher protein intake is especially beneficial
in the prevention of mobility limitation rather than reversing it,
because it might be too late when mobility limitation develops,
and emphasize the importance of early screening for lower
protein intake and early (dietary) intervention.
The debate about whether the RDA for protein for older adults,
currently 0.8 g/kg BW/d according to the EFSA (35) and IoM
(36), should be increased, and to what extent, is still ongoing.
Our results tend to show that the relation between protein intake
and decline in walking speed is dose-dependent. There was
also a small reduction in the likelihood of incident difficulty
walking with higher protein intake categories (0.8–0.99, 1.0–
1.19, and ≥1.2 g/kg aBW/d) suggesting, as for walking speed,
a dose-dependent association, although this was not observed
for difficulty climbing stairs. These findings suggest that higher
protein intake might benefit walking function not only in older
adults with a protein intake below the RDA, but also in those with
a habitual protein intake of ∼1.0 g/kg BW/d [mean protein intake
in community-dwelling European and North American older
adults (17)]. Our findings are in line with results from the study
by Beasley et al. (12), in which the rate of self-reported physical
function decline was 52% lower in females with a mean protein
intake of 1.19 ± 0.20 g/kg BW/d than in females with a protein
intake of 0.97 ± 0.17 g/kg BW/d. Together, these results suggest
that even a protein intake >1.2 g/kg BW/d might be better in
terms of slowing the rate of physical function decline. However,
as such a (high) protein recommendation could have many
substantial implications (e.g., for >70% of community-dwelling
older adults, health care, food industry, and environment), such
recommendations should only be set when sufficient high-quality
evidence is available. More observational studies and RCTs in
well-characterized study samples with adequate follow-up are
needed to define the optimal yet feasible protein intake in older
adults as well as the optimal food sources for the additional
protein.
Several experts have suggested that (higher) PA could have
an additive or synergistic effect on muscle and physical function
when combined with protein intake (18). We did not find a clear
indication for effect modification by PA or a synergistic effect
of protein and PA. We observed a trend of higher protein intake
categories being more protective for walking speed and walking
speed decline within both the low and high PA category, but
these did not reach statistical significance. This is probably a
consequence of the small decline in walking speed over time.
Participants with higher protein intake (even ≥0.8 g/kg aBW/d)
were less likely to transition to mobility limitation, within each
PA level. This suggests that 1) higher protein intake can protect
from the incidence of mobility limitation independently of PA
level, and 2) participants with protein intake ≥0.8 g/kg aBW/d
still benefit from higher protein intake within the same PA
level (i.e., a protein intake ≥1.2 g/kg aBW/d has a greater
protective association with incident mobility limitations than 0.8–
0.99 g/kg aBW/d). Similar to our findings, 1 systematic review
of 15 RCTs in older adults on the additive effect of protein
supplementation and progressive resistance exercise for 2–5
times/wk over 7 wk to 1 y found that improvements in physical
function were no different with protein supplementation alone or
in combination with resistance exercise (23). A later systematic
review of 36 RCTs in nonfrail older adults concluded that walking
speed tended to improve more with protein supplementation
in combination with resistance exercise after 26 ± 26 wk
compared with resistance exercise only (22). Differences in the
type, intensity, and duration of PA or the timing in relation to
protein intake might account for different effects of PA (and its
interaction with protein) on physical function.
A major strength of this study is that we harmonized data from
4 large aging cohorts and performed an individual participant
pooled analysis, allowing us to significantly increase our sample
size and test for interactions that we could not test otherwise.
The use of objective (walking speed) and subjective (mobility
limitations) measures of physical function, the large range of
covariates adjusted for, and the use of joint modeling and
multistate models to account for nonrandom attrition and study
membership, are other major strengths of this study.
One possibly important limitation in our study is misreporting
of dietary intakes. However, because protein-rich foods are less
commonly underreported (unlike snacks and sweets) (65) it is
unlikely that protein intakes were underestimated. Additionally,
although protein intake was harmonized, dietary intake was
assessed by FFQs in Health ABC and LASA, and with multiple
24-h recalls in NuAge and Newcastle 85+, 2 methods that
might give slightly different estimates. Another limitation is that
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intakes were assumed to be stable or have declined proportionally
over the follow-up period. A fourth limitation is that mobility
limitation states were assigned at every data collection point
(mean =1.70 ± 0.55 y) between each wave but unobserved
incidence and recovery from these mobility limitation states
could have occurred between waves. Finally, although attempts
were made to reduce the possibility of reverse causality it is
impossible to fully exclude the possibility of protein intake being
affected by physical function.
In conclusion, increasing daily protein intake can reduce
physical function decline over 8.5 y not only in community-
dwelling older adults with a protein intake at or below the current
RDA of 0.8 g/kg BW/d, but also in those with a protein intake that
is already considered sufficient. This dose-dependent association
was observed for each level of PA, suggesting no clear synergistic
association between protein intake and PA in relation to physical
function.
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